1. Hong Kong Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Qinghai Biotech Pharmaceutical Group Limited

Qinghai Biotech Pharmaceutical Group Limited

HHKEX:876
1.53
HKD
0.00
(0.00%)
352.95MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6.16
6.87
1.41
2.52
2.87
2.38
2.5
1.82
2.08
1.9
1.84
1.84
1.38
- -
Basic EPS, GAAP
-0.69
-1.7
-0.43
-0.2
0.05
-0.22
-3.52
-0.39
0.02
-1.22
0.07
-0.46
-0.46
- -
Free Cash Flow per Basic Share
0.03
-2.83
0.74
0.09
-0.07
-0.34
-0.23
-0.61
-1.61
-0.72
-0.46
-0.39
-0.58
- -
Dividend per Share
- -
1.82
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
6.54
2.29
6.63
6.59
10.22
9.97
6.37
6.31
6.46
4.81
4.88
4.28
4
4
Tangible Book Value per Share
6.54
2.29
1.92
1.89
6.7
6.41
6.36
5.64
5.92
4.31
4.64
4.04
3.76
3.76
Basic Weighted Avg Shares
51
53
71
75
79
102
101
101
101
101
101
101
101
101
Sales/Revenue/Turnover
316
363
100
188
227
242
252
184
210
191
186
185
139
- -
Operating Margin (%)
-3.99
-17.1
-5.6
6.53
8.32
-1.63
2.24
-9.29
-26.67
-33.74
-21.99
-12.56
-37.62
- -
Depreciation Expense
31
20
5
4
4
8
15
21
27
31
18
15
13
- -
Net Income, GAAP
-36
-90
-31
-15
4
-22
-355
-40
2
-123
7
-46
-47
- -
Effective Tax Rate (%)
- -
- -
- -
114
59.2
- -
- -
- -
210
- -
- -
- -
- -
- -
Profit Margin (%)
-11.25
-24.76
-30.65
-8.07
1.73
-9.11
-140.96
-21.59
1.13
-64.4
4.02
-25.01
-33.55
- -
Working Capital
88
17
197
104
625
449
345
240
314
205
253
228
193
193
LT Debt
- -
- -
- -
- -
- -
- -
5
17
26
25
10
6
8
8
Total Equity
335
212
567
507
1,043
1,005
642
648
683
471
492
426
398
398
Return on Invested Capital (%)
- -
- -
- -
-0.31
0.99
- -
- -
- -
5.84
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-1.88
0.66
- -
- -
- -
1.16
- -
- -
- -
- -
- -
Return on Common Equity (%)
-4.87
-37.8
-9.45
-3
0.51
-2.15
-43.07
-6.21
0.37
-21.7
1.53
-10.04
-11.19
- -

Capital Structure

HKD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
4
- -
5
LT Borrowings
- -
- -
- -
LT Finance Leases
6
- -
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
101
101
101
Market Capitalization
121
96
353

Working Capital

HKD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
312
- -
257
Cash, Cash Equivalents & STI
150
- -
110
Accounts Receivable, Net
111
- -
76
Inventories
13
- -
15
Total Current Liabilities
84
- -
65
Payables & Accruals
- -
- -
- -
ST Debt
4
- -
5
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.54%
-8.2%
-6.56%
Free Cash Flow
50.9%
21.43%
49.46%
Net Income, GAAP
-567.87%
-1,251.91%
0.7%
Sales/Revenue/Turnover
6.99%
-4.55%
-24.95%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
186
2024
- -
- -
185
2025
- -
- -
139

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.07
2024
- -
- -
-0.46
2025
- -
- -
-0.46

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Jun Luo
Full Time Employees
825
Sector
Health technology
Industry
Medical specialties
Address
The Center Hong Kong Hong Kong
IPO Date
Sep 29, 2005
Website
kaisahealth.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Kaisa Health Group Holdings Limited (0876.HK) is an investment holding company principally engaged in the manufacture and sale of dental prosthetics and related products, as well as the provision of healthcare services including sports rehabilitation and health leisure offerings. The company produces and sells a range of dental prosthetics such as crowns and bridges, removable full and partial dentures, dental implants, full-cast restorations, veneers, and implant instruments; it also engages in medical technology development, medical consultation, and other medical services targeting dental clinics, healthcare providers, and consumers primarily in the People's Republic of China, Hong Kong, and international markets. Incorporated in Bermuda and listed on the Stock Exchange of Hong Kong, Kaisa Health Group Holdings Limited was founded in 1971 and is headquartered at 30/F, The Center, 99 Queen's Road Central, Central, Hong Kong, with additional operations in Shenzhen. In a recent development, the company terminated a proposed acquisition of additional 3.4904% limited partnership interests in Zhuhai Jinyiming Equity Investment Fund Partnership (L.P.) on July 23, 2025, after conditions precedent were not met by the longstop date. Formerly known as Mega Medical Technology Limited, it changed its name to Kaisa Health Group Holdings Limited in January 2018 and operates through segments including dental business, health care, and rehabilitation services, with sales primarily in mainland China.